Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24 Phase 3 Results Expected
0 competitors in Non-Proliferative Diabetic Retinopathy
View Full LandscapeTarget Indication
Non-Proliferative Diabetic Retinopathy
Clinical Trial
NCT07235085Last updated: 12/4/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Open Angle Glaucoma and Ocular Hypertension
Post-Surgical Ocular Pain
Post Ocular Surgical Inflammation and Pain
Neovascular Age-Related Macular Degeneration
Cataract